ESG

BMW Group and Quantinuum expand their landmark collaboration, leveraging next-gen quantum computers to revolutionize materials for future electric and fuel cell vehicles.

A first-of-its-kind P&C product aims to protect small medical practices from unique financial risks, launched in record time on an agile insurtech platform.

A novel gene therapy aims to cross the blood-brain barrier, offering new hope for Tuberous Sclerosis Complex, thanks to a powerful new partnership.

NiSource secures top sustainability honors for over a decade. Explore how its deep ESG strategy is setting an industry benchmark and attracting investors.

A new biotech emerges with a promising, late-stage gene therapy for Sanfilippo syndrome, offering a potential lifeline for children with no other options.

With profits up and a new CEO, TVA is pouring billions into new generation, betting on advanced nuclear power to meet soaring demand from data centers.

Atkore's Q2 revenue rose 4.2%, but a $136.5M antitrust settlement drove a major net loss. The company divests assets to focus on its electrical core.

Giyani Metals' high-purity manganese meets quality standards from US tech leader C4V, a crucial step in building a non-Chinese battery supply chain.

New research reveals CFO salaries are surging toward $4M, yet tenures are plummeting. A look at the high-risk, high-reward world of modern finance chiefs.

UK biotech Cytospire Therapeutics secures major funding to push its safer, more selective gamma delta T-cell engager into clinical trials for solid tumors.

UK biotech Cytospire secures a major Series A to bring its novel pan-gamma delta T cell engagers, targeting tough solid tumors, into clinical trials.

neurocare's TMS device approval marks a major shift in the Kingdom's approach to depression, prioritizing non-invasive, tech-driven solutions.

Meren Energy's upcoming Q1 2026 results will be scrutinized for its performance in Africa's deepwater projects amidst soaring oil prices and strategic shifts.

A new AI voice agent from Zibu promises to solve after-hours communication woes, reduce missed appointments, and alleviate doctor burnout. But can it stand out?

The trust advances major Toronto developments and improves its debt position, signaling a long-term strategy amid a challenging real estate market.

As Spruce Power preps its Q1 results, investors watch to see how the firm is navigating the end of key tax credits and rising competition.

Enabled Talent launches a fellowship with a radical promise: it won't end until participants secure a job, bridging the gap from readiness to results.

A landmark partnership between Anthem and Ohio chambers marks 10 years, covering 94,000 people and reshaping affordable healthcare for small employers.

Valion Bio's new General Counsel, a rare blend of scientist and lawyer, is poised to navigate its radiation drug through the FDA's complex Animal Rule.

CTIBIOTECH brings revolutionary 3D human tissue printing to 'Cellicon Valley,' aiming to slash drug failures and accelerate personalized medicine.